LENSAR Inc (LNSR NASDAQ) stock market data APIs
$5.6058
-0.33(-5.9%)
as of May 8, 2026
Try our APIs with
free plan!
LENSAR Inc Financial Data Overview
Price chart is built with
Anychart
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Prev. Close
5.6058
Open
5.2721
High
5.9573
Low
5.1893
52 wk Range
5.06-14.3099
Market Cap
68 268 K
Shares Outstanding
12 104 K
Revenue
58 435 K
EPS
-0.1964
Beta
0.844
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with LENSAR Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get LENSAR Inc data using free add-ons & libraries
Get LENSAR Inc Fundamental Data
LENSAR Inc Fundamental data includes:
- Net Revenue: 58 435 K
- EBITDA: -20 076 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: 0.49
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LENSAR Inc News
New
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
LENSAR, Inc. 7 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 m...
How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The updated analyst narrative around LENSAR now centers o...
Cedar Grove Capital Management’s Views on LENSAR (LNSR)
Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter can be downloaded here. Cedar Grove Capital Management�...
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The reset in LENSAR’s fair value price target from $12.50...
Get LENSAR Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
